Phenotypes Associated with This Genotype

Genotype
MGI:6288411

• Allelic Composition: Cyp19a1^{tm1b(EUCOMM)Hmgu}/Cyp19a1^{tm1b(EUCOMM)Hmgu}
• Genetic Background: C57BL/6N-Cyp19a1^{tm1b(EUCOMM)Hmgu}/H
• Cell Lines: HEPD0631_4_E05

Data Sources

IMPC Data for Cyp19a1

• ♀: phenotype observed in females
• ♂: phenotype observed in males
• N: normal phenotype

adipose tissue

increased total body fat amount ( J:211773 )

IMPC - HAR

behavior/neurological

decreased exploration in new environment ( J:211773 )

♀

IMPC - HAR

increased anxiety-related response ( J:211773 )

IMPC - HAR

tremors ( J:211773 )

♂

IMPC - HAR

abnormal gait ( J:211773 )

♂

IMPC - HAR

decreased locomotor activity ( J:211773 )

IMPC - HAR

growth/size/body

decreased lean body mass ( J:211773 )

IMPC - HAR

hematopoietic system

decreased mean corpuscular hemoglobin concentration ( J:211773 )

♀

IMPC - HAR

increased neutrophil cell number ( J:211773 )

♂

IMPC - HAR

thrombocytosis ( J:211773 )

♀

IMPC - HAR

decreased leukocyte cell number ( J:211773 )

♂

IMPC - HAR

decreased lymphocyte cell number ( J:211773 )

♂

IMPC - HAR

homeostasis/metabolism

increased fasting circulating glucose level ( J:211773 )

♂

IMPC - HAR

increased circulating cholesterol level ( J:211773 )

♂

IMPC - HAR

decreased circulating iron level ( J:211773 )

IMPC - HAR

decreased circulating alkaline phosphatase level ( J:211773 )

♀

IMPC - HAR

increased circulating aspartate transaminase level ( J:211773 )

♂

IMPC - HAR

increased circulating serum albumin level ( J:211773 )

♂

IMPC - HAR

increased blood urea nitrogen level ( J:211773 )

IMPC - HAR

immune system

increased neutrophil cell number ( J:211773 )

♂

IMPC - HAR

decreased leukocyte cell number ( J:211773 )

♂

IMPC - HAR

decreased lymphocyte cell number ( J:211773 )

♂

IMPC - HAR